Liposomal curcumin is any type of curcumin supplement that has been encapsulated in a liposome. A liposome is a type of tiny vesicle with a phospholipid outer layer, used to improve the fat solubility of dietary ingredients.
This is done to improve absorption and systemic bioavailability of curcumin extract. Research shows that liposomal delivery of therapeutic substances increases bioavailability by as much as 1500%.
Curcumin is the bioactive constituent in turmeric (curcuma longa). Curucmin is associated with a number of health benefits, including improved protection from oxidative damage, a reduction in inflammation and improved joint functionality.
Curcumin supplements are widely used, but many are poorly absorbed in humans after ingestion. The use of a liposomal curcumin liquid or capsule can improve absorption, allowing the consumer to take a smaller dosage to derive beneficial effects.
According to the manufacturers of one liposomal turmeric extract, this supplement supports antioxidant activities, the elimination of toxins, immune function, healthy aging and healthy cholesterol levels.



- Effective anti-inflammatory supplement
- Shown to improve joint functionality
- Anti-oxidant to supper general health
What are Liposomes?
Related Topics
A liposome is a spherical sac containing at least one phospholipid bilayer. Liposomes are used to deliver various medicines and nutrients.
Liposomes result from altering the structures of biological membranes; normally via sonication (exposure to sound energy).
Research supports using liposomal delivery for certain medication types. This delivery method is effective for minimizing toxicity potentials and enhancing medication efficacy.
Liposomal delivery is particularly useful for medications with narrow therapeutic indices that require carrier agents. Carrier drugs are capable of altering the pharmacokinetics and biodistribution of given medicines.
Some of the benefits of liposomal delivery include:
- Selectively passive targeting of immunity cells;
- Improved lipophilic and amphiphilic solubility;
- Increased penetration of targeted tissues;
- Increased hydrophilic molecule transfer;
- Sustained local and systemic release;
Liposomal delivery of medicinal agents allows more of the medicinal substances to reach targeted tissues.
This is accomplished with minimal degradation of pure substances. In many cases, the necessary dose of a given substance is decreased by between 10 and 15 times because of liposomal delivery.
Liposomal Curcumin Benefits
Curcumin is a strong antioxidant and anti-inflammatory agent. It also demonstrates anticancer, antidiabetic, cardioprotective, antibacterial, antiviral, immunomodulatory and neuroprotective potentials in research studies.
The antioxidant effects of curcumin protect DNA and cell membranes from damages that can lead to disease. Preliminary research has examined the effects of curcumin on cancer development and progression. In in vitro and in vivo studies, it has demonstrated effects against breast, colon, skin and prostate cancer.
Some human research suggests that curcumin can improve plasma lipid balance. It may help to decrease low density lipoprotein (LDL) cholesterol, total cholesterol and triglycerides. It may also help to elevate HDL (good) cholesterol.
By decreasing serum cholesterol and triglycerides, liposomal curcumin is believed by some medical experts to reduce the risks of atherosclerosis, the leading cause of coronary artery disease and heart disease.
However, more research studies are needed to validate this claim. It has not been approved by the FDA for the prevention or treatment of heart disease.
Liposomal curcumin administration may also help to reduce the formation of amyloid plaque that has been linked to Alzheimer’s disease. It has also been researched for its effects on Parkinson’s disease, dementia and other neurodegenerative disorders.
Uses for Liposomal Curcumin
There has been a lot of progress in liposomal drug delivery research recently. It is especially useful at increasing aqueous solubility and systemic bioavailability of certain substances with poor absorption, like curcumin.
Curcumin is used for a wide range of health-enhancing purposes. The Natural Medicines Comprehensive Database states the following curcumun uses:
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis (RA);
- Irritable bowel syndrome;
- Alzheimer’s disease;
- Kidney inflammation;
- Loss of appetite;
- Peptic ulcers;
Turmeric and curcumin are also used for headaches, fatigue, bronchitis, hyperlipidemia, parasitic worms and tuberculosis. However, it has not been approved by the FDA for the treatment of any specific medical conditions.
Liposomal Curcumin and Pancreatic Cancer
Research shows that liposomal curcumin inhibits cellular proliferation and suppresses growth in human MiaPaCa pancreatic tumor cells. These effects occurred in both xenograft and in vitro studies.
Xenografted tumors in nude mice were suppressed by at least 42% within 4 weeks with daily administration.
Liposomal Curcumin Side Effects
There are no serious or permanent adverse effects associated with proper curcumin usage. It demonstrates very low toxicity and high tolerability in most healthy people.
In rare cases, nausea, vomiting, bloating, diarrhea and/or stomach discomfort result from usage. These symptoms pass on their own quickly in most cases.
Liposomal Curcumin Interactions
Certain disease, drug, herb and supplement interactions are possible. You should be cautious if using liposomal curcumin in conjunction with antiplatelet, anticoagulant and/or antidiabetic medications or herbs.
Liposomal curcumin may also interact adversely with P-glycorpotein substartes, P450 cytochrome substrates, norfloxacin, sulfasalazine, pacitaxel, docetaxel and talinolol.
If you have an iron deficiency, then talk to your doctor before taking liposomal curcumin. It may bind with iron and suppress its absorption.
Seek medical advice before beginning to use liposomal curcumin products if you have a hormone-sensitive cancer, heart disease, diabetes mellitus, gallbladder obstruction or bile duct disorder.
Conclusions
Curcumin is believed to be a multi-therapeutic substance that causes very few adverse side effects in the majority of users. Traditional use for thousands of years has also demonstrated its general safety.
If you are considering using a liposomal curcumin supplement, then ensure that you choose a supplement with an established reputation for quality and efficacy. Always follow manufacturer’s dosing recommendations carefully and self-monitor for adverse side effects.
- Al-Karawi D1, Al Mamoori DA2, Tayyar Y3. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials. Phytother Res. 2015 Nov 27. doi: 10.1002/ptr.5524. [Epub ahead of print]
- Chen Q1, Gao Q1, Chen K1, Wang Y1, Chen L1, Li XU2. Curcumin suppresses migration and invasion of human endometrial carcinoma cells. Oncol Lett. 2015 Sep;10(3):1297-1302. Epub 2015 Jul 9.
- Poojan S1, Kumar S1, Verma V1, Dhasmana A2, Lohani M3, Verma MK1. Disruption of Skin Stem Cell Homeostasis following Transplacental Arsenicosis; Alleviation by Combined Intake of Selenium and Curcumin. PLoS One. 2015 Dec 1;10(12):e0142818. doi: 10.1371/journal.pone.0142818. eCollection 2015.
- Du L, Feng X, Xiang X, Jin Y1. Wound Healing Effect of an in Situ Forming Hydrogel Loading Curcumin-Phospholipid Complex. Curr Drug Deliv. 2015 Dec 2. [Epub ahead of print]
- Ding L1, Ma S2, Lou H3, Sun L4, Ji M5. Synthesis and Biological Evaluation of Curcumin Derivatives with Water-Soluble Groups as Potential Antitumor Agents: An in Vitro Investigation Using Tumor Cell Lines. Molecules. 2015 Dec 2;20(12):21501-14. doi: 10.3390/molecules 201219772.
- Huang H1, Chen X1, Li D2, He Y1, Li Y3, Du Z1, Zhang K1, DiPaola R4, Goodin S4, Zheng X1. Combination of ?-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells. PLoS One. 2015 Dec 2;10(12):e0144293. doi: 10.1371/journal.pone.0144293. eCollection 2015.
- Li L1, Li H2, Li M2. Curcumin protects against cerebral ischemia-reperfusion injury by activating JAK2/STAT3 signaling pathway in rats. Int J Clin Exp Med. 2015 Sep 15;8(9):14985-14991.
- Ramadan G1, El-Menshawy O. Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis. Int J Rheum Dis. 2013 Apr;16(2):219-29. doi: 10.1111/1756-185X.12054. Epub 2013 Apr 4.
- Velusami CC1, Boddapati SR1, Hongasandra Srinivasa S1, Richard EJ1, Joseph JA1, Balasubramanian M1, Agarwal A1. Safety evaluation of turmeric polysaccharide extract: assessment of mutagenicity and acute oral toxicity. Safety evaluation of turmeric polysaccharide extract: assessment of mutagenicity and acute oral toxicity.
- Chainani-Wu N1. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcumalonga). J Altern Complement Med. 2003 Feb;9(1):161-8.
- Boyanapalli SS1, Tony Kong AN1. "Curcumin, the King of Spices": Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases. Curr Pharmacol Rep. 2015 Apr;1(2):129-139. Epub 2015 Jan 30.
- Witkin JM1, Li X. Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy. CNS Neurol Disord Drug Targets. 2013 Jun;12(4):487-97.
- Bandyopadhyay D1. Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer. Front Chem. 2014 Dec 23;2:113. doi: 10.3389/fchem.2014.00113. eCollection 2014.
- Zhao G1, Han X1, Zheng S1, Li Z1, Sha Y1, Ni J1, Sun Z1, Qiao S1, Song Z1. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Oncol Rep. 2015 Nov 12. doi: 10.3892/or.2015.4413. [Epub ahead of print]
- Yu CC1, Yang MD2, Lin HY1, Huang AC3, Lin JP4, Kuo CL5, Liu KC6, Liu HC7, Yang ST8, Chung JG9. Bisdemethoxycurcumin (BDMC) Alters Gene Expression-associated Cell Cycle, Cell Migration and Invasion and Tumor Progression in Human Lung Cancer NCI-H460 Cells. In Vivo. 2015 11-12;29(6):711-728.
- Ma J1, Jin X, Yang L, Liu ZL. Diarylheptanoids from the rhizomes of Zingiber officinale. Phytochemistry. 2004 Apr;65(8):1137-43.
- Zheng Z1, Sun Y2, Liu Z1, Zhang M1, Li C1, Cai H3. The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats. Drug Des Devel Ther. 2015 Aug 27;9:4931-42. doi: 10.2147/DDDT.S90147. eCollection 2015.
- Bandyopadhyay, Debasish. "Farmer to Pharmacist: Curcumin as an Anti-Invasive and Antimetastatic Agent for the Treatment of Cancer." Frontiers in Chemistry 2 (2014): 113. PMC. Web. 24 Nov. 2015.
- Bordoloi D, Roy NK, Monisha J, Ganesan P, Kunnumakkara AB1. Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far. Recent Pat Anticancer Drug Discov. 2015 Oct 19. [Epub ahead of print]
- Sarker MR1, Franks S2, Sumien N1, Thangthaeng N1, Filipetto F2, Forster M1. Curcumin Mimics the Neurocognitive and Anti-Inflammatory Effects of Caloric Restriction in a Mouse Model of Midlife Obesity. PLoS One. 2015 Oct 16;10(10):e0140431. doi: 10.1371/journal.pone.0140431. eCollection 2015.
- Ravindran, Jayaraj, Sahdeo Prasad, and Bharat B. Aggarwal. "Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?" The AAPS Journal 11.3 (2009): 495–510. PMC. Web. 24 Nov. 2015.
- Schaffer M1, Schaffer PM, Bar-Sela G. An update on Curcuma as a functional food in the control of cancer and inflammation. Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):605-11. doi: 10.1097/MCO.0000000000000227.
- Winkler A1, Gessner DK2, Koch C3, Romberg FJ3, Dusel G1, Herzog E4, Most E2, Eder K2. Effects of a plant product consisting of green tea and curcuma extract on milk production and the expression of hepatic genes involved in endoplasmic stress response and inflammation in dairy cows. Arch Anim Nutr. 2015 Dec;69(6):425-41. doi: 10.1080/1745039X.2015.1093873.
- Iranshahi M1, Chini MG2, Masullo M2, Sahebkar A1, Javidnia A3, Chitsazian Yazdi M1, Pergola C4, Koeberle A4, Werz O4,Pizza C2, Terracciano S2, Piacente S2, Bifulco G2. Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? The Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors. J Nat Prod. 2015 Nov 20. [Epub ahead of print]
- Kocaadam B1, ?anlier N1. Curcumin, an Active Component of Turmeric (Curcuma longa), and Its Effects on Health. Crit Rev Food Sci Nutr. 2015 Nov 3:0. [Epub ahead of print]
- Lovelace ES1, Polyak SJ2,3,4. Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection. Viruses. 2015 Nov 30;7(12):6218-32. doi: 10.3390/v7122933.
- Bharat B. Aggarwal1 and Kuzhuvelil B. Harikumar Potential Therapeutic Effects of Curcumin, the Anti-inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases Int J Biochem Cell Biol. 2009; 41(1): 40–59. Published online 2008 Jul 9. doi: 10.1016/j.biocel.2008.06.010
- Kim SK1, Seok H1, Park HJ1, Jeon HS1, Kang SW1, Lee BC2, Yi J2, Song SY2, Lee SH3, Kim YO4, Chung JH5. Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model. BMC Complement Altern Med. 2015 Oct 22;15(1):380. doi: 10.1186/s12906-015-0825-y.
- Prasad S, Aggarwal BB. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 13.
- Gupta, Subash C., Sridevi Patchva, and Bharat B. Aggarwal. "Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials." The AAPS Journal 15.1 (2013): 195–218. PMC. Web. 8 Dec. 2015.
- He Y1, Yue Y2, Zheng X3,4, Zhang K5, Chen S6, Du Z7. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015 May 20;20(5):9183-213. doi: 10.3390/molecules 20059183.
- He YJ, Kuchta K, Lv X, Lin Y, Ye GR, Liu XY, Song HD, Wang LX, Kobayashi Y, Shu JC. Curcumin, the main active constituent of turmeric (Curcuma longa L.), induces apoptosis in hepatic stellate cells by modulating the abundance of apoptosis-related growth factors. Z Naturforsch C. 2015 Nov 1;70(11-12):281-5. doi: 10.1515/znc-2015-4143.
- Shoba G1, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May;64(4):353-6.
- Nimiya Y1,2, Wang W1, Du Z1, Sukamtoh E1, Zhu J1, Decker E1, Zhang G1. Redox modulation of curcumin stability: Redox active antioxidants increase chemical stability of curcumin. Mol Nutr Food Res. 2015 Nov 26. doi: 10.1002/mnfr.201500681. [Epub ahead of print]
Article last updated on: April 10th, 2018 by Nootriment
1 Comment
BONJOUR
Quelqu’un aurait il un fabriquant à me conseiller
Je suis perdu parmi tous les vendeurs
Je recherche de préférence une formule avec lécithine de tournesol plutôt que du soja. le soja pouvant être dangereux pour les cancers hormono depedants.
Cordialement